Sam J L相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80+Clec4f+Vsig4+Ly6C- Kupffer Cell Subsets

脂多糖通过激活 F4/80+Clec4f+Vsig4+Ly6C- 库普弗细胞亚群降低胆固醇酯转运蛋白

期刊:Journal of the American Heart Association

doi:10.1161/JAHA.117.008105

Sam J L van der Tuin, Zhuang Li, Jimmy F P Berbée, Inge Verkouter, Linda E Ringnalda, Annette E Neele, Jan B van Klinken, Sander S Rensen, Jingyuan Fu, Menno P J de Winther, Albert K Groen, Patrick C N Rensen, Ko Willems van Dijk, Yanan Wang

细胞生物学

发表日期：2018

文献求助收藏

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin

阿那西曲匹主要通过降低非高密度脂蛋白胆固醇水平来减缓动脉粥样硬化的进展，改善病变稳定性，并增强阿托伐他汀的疗效。

期刊:European Heart Journal

影响因子:35.6

doi:10.1093/eurheartj/ehu319

Kühnast, Susan; van der Tuin, Sam J L; van der Hoorn, José W A; van Klinken, Jan B; Simic, Branko; Pieterman, Elsbet; Havekes, Louis M; Landmesser, Ulf; Lüscher, Thomas F; Willems van Dijk, Ko; Rensen, Patrick C N; Jukema, J Wouter; Princen, Hans M G

动脉粥样硬化

发表日期：2015

文献求助收藏

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9

Anacetrapib 通过抑制 CETP 活性和降低血浆 PCSK9 来降低 (V)LDL 胆固醇

期刊:Journal of Lipid Research

doi:10.1194/jlr.M057794

Sam J L van der Tuin, Susan Kühnast, Jimmy F P Berbée, Lars Verschuren, Elsbet J Pieterman, Louis M Havekes, José W A van der Hoorn, Patrick C N Rensen, J Wouter Jukema, Hans M G Princen, Ko Willems van Dijk, Yanan Wang

发表日期：2015

文献求助收藏